UBriGene Biosciences collects $20m in Series C-plus financing

The round follows the close of uBriGene’s Series C financing in September 2022.

3 May 2023•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.